Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous s stock reports and market updates.
AngioDynamics, Inc. (NASDAQ: ANGO) shares gained 5.74 percent to close at $16.76 a share Wednesday. The stock traded between $16.07 and $16.90 on volume of 340,329 shares traded. Analysts at Raymond James have recently upgraded the company’s rating to “outperform” from “market perform”. Shares of AngioDynamics have fallen approximately 2.0 percent year-to-date.
Find out more about AngioDynamics including full access to the free equity report at:
Calix Inc. (NYSE: CALX) shares increased 2.77 percent to close at $8.89 a share Wednesday. The stock traded between $8.78 and $9.03 on volume of 705,885 shares traded. Analysts at Goldman Sachs have recently upgraded the company’s rating to “neutral” from “sell”. Shares of Calix have fallen approximately 8.0 percent year-to-date.
Find out more about Calix including full access to the free equity report at:
Horizon Technology Finance Corp. (NASDAQ: HRZN) shares fell 11.84 percent to close at $12.43 a share Wednesday. The stock traded between $12.17 and $13.23 on volume of 666,360 shares traded. Analysts at Keefe Bruyette & Woods have recently downgraded the company’s rating to “underperform” from “market perform”. Shares of Horizon Technology Finance have fallen approximately 12.5 percent year-to-date.
Find out more about Horizon Technology Finance including full access to the free equity report at:
Silicon Laboratories (NASDAQ:SLAB) shares increased 1.22 percent to close at $52.93 a share Wednesday. The stock traded between $51.99 and $53.27 on volume of 203,339 shares traded. Analysts at Piper Jaffray have recently initiated coverage on the company with an “overweight” rating and have raised its price target to $58.00. Shares of Silicon Laboratories have fallen approximately 4.0 percent year-to-date.
Find out more about Silicon Laboratories including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing